Begin dietary adjustments immediately
As Ozempic and Wegovy continue to be popular choices for managing diabetes and obesity, the ongoing research into their side effects like gastroparesis will remain a critical component of patient care
Meanwhile, Ozempics once-weekly dosing, significant weight loss potential, and cardiovascular benefits make it a comprehensive choice for many patients
Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound)
Telehealth offers a unique advantage for managing GLP-1 medications
Various treatment modalities are employed to cure infertility, but the success rate remains low